Skip to content

Point to the commercial edition and take a relicensing grant from contributors #201

New issue

Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community.

Sign up for GitHub

By clicking “Sign up for GitHub”, you agree to our terms of service and privacy statement. We’ll occasionally send you account related emails.

Already on GitHub? Sign in to your account

Merged
Jing-yilin merged 3 commits into from
Sep 28, 2026
Merged

Point to the commercial edition and take a relicensing grant from contributors #201

Show file tree
Hide file tree
Changes from 1 commit
Commits
Show all changes
3 commits
Select commit Hold shift + click to select a range
380ce53
Point to the commercial edition and take a relicensing grant from con…
Jing-yilin Sep 28, 2026
74b9912
Say third-party material in canvases/ is not ours and not in the product
Jing-yilin Sep 28, 2026
0a5d374
Correct the tldraw and template-shell notes, and name the company in …
Jing-yilin Sep 28, 2026
File filter

Filter by extension

Filter by extension
Conversations
Failed to load comments.
Loading
Jump to
Jump to file
Failed to load files.
Loading
Diff view
Diff view
5 changes: 4 additions & 1 deletion CONTRIBUTING.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -157,4 +157,7 @@ through private vulnerability reporting; see `SECURITY.md`.
## License

By contributing you agree that your contribution is licensed under the
Apache License 2.0, the same as the rest of the repository.
Apache License 2.0, the same as the rest of the repository, and you grant
ReScience Lab Inc. a perpetual, worldwide, royalty-free, irrevocable licence to
use, modify, sublicense and relicense it under any terms, including in its
commercial editions. You confirm the contribution is yours to give.
Comment on lines +160 to +163

@chatgpt-codex-connector chatgpt-codex-connector Bot Sep 28, 2026

Copy link
Copy Markdown

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

P1 Badge Record the relicensing decision in docs

Introducing a perpetual right to relicense contributions is a long-lived licensing-policy decision, but its rationale currently exists only in the commit message. Future maintainers evaluating or changing the commercial-licensing model will not have that context in the repository; add a dated decision document explaining the grant's scope and rationale.

AGENTS.md reference: AGENTS.md:L136-L136

Useful? React with 👍 / 👎.

10 changes: 9 additions & 1 deletion README.md
View file
Open in desktop
Original file line number Diff line number Diff line change
Expand Up @@ -262,9 +262,17 @@ version's section in `RELEASE-NOTES.md`, then merge: the tag
The whole procedure, including what to do when a step fails, is under "Cutting a
release" in `CONTRIBUTING.md`.

## Commercial edition

This repo is the open-source edition, free to use. A commercial edition is
packaged and supported for studios and teams, from ReScience Lab Inc.
Pricing is by conversation: write to
[yilin.jing@rescience.com](mailto:yilin.jing@rescience.com) with your team size
and what you want to use it for.
Comment on lines +265 to +271

@devin-ai-integration devin-ai-integration Bot Sep 28, 2026

Copy link
Copy Markdown

Choose a reason for hiding this comment

The reason will be displayed to describe this comment to others. Learn more.

🔍 Commercial announcement has no release note

The commercial edition announcement is user-visible, but ## Unreleased has no matching entry. Contribution rules require one; the PR checklist claims documentation needs none.

Devin Review

Was this helpful? React with 👍 or 👎 to provide feedback.


## Licence

This repo is Apache-2.0 (see `LICENSE`).
This repo is Apache-2.0 (see `LICENSE`), © ReScience Lab Inc.

**The tldraw SDK it depends on is not.** tldraw ships under the
[tldraw licence](https://github.com/tldraw/tldraw/blob/main/LICENSE.md): free
Expand Down
Loading